A view on drug resistance in cancer
Neil Vasan(Columbia University Irving Medical Center), David M. Hyman(Memorial Sloan Kettering Cancer Center)
Cited by 2,682
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
|Cell stem cell|2017|851
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739